Trial intelligence / Profile preview

Effect of Longqi Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease

NCT07320456Phase 2Not yet recruiting

Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Start
Dec 2025
Primary completion
May 2026
Modality
Small Molecules
01

Overview

A Phase 2 trial of Longqi Jiangzhi decoction in non-alcoholic fatty liver disease (NAFLD), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

Longqi Jiangzhi decoction
03

Conditions

non-alcoholic fatty liver disease (NAFLD)

Beyond the preview

Go deeper on NCT07320456.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07320456.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call